Human Monoclonal Antibodies: MD.03.1H06, MD.03.1B06, MD.03.1D11, MD.031F03, MD.03.1F11, MD.03.1H01, MD.025.2H09, MD.03.1G01, MD.025.2F10, MD.025.2B07, MD.025.2G11, MD.025.1F09, MD.025.1D01, MD.025.1H07, 306.012.7.1C10, 306.012.7.1A05, 10.036.7.1B04, 10.04.7.1B03

by | Apr 8, 2020 | Ellebedy, Ali

— Human Monoclonal Antibodies: MD.03.1H06, MD.03.1B06, MD.03.1D11, MD.031F03, MD.03.1F11, MD.03.1H01, MD.025.2H09, MD.03.1G01, MD.025.2F10, MD.025.2B07, MD.025.2G11, MD.025.1F09, MD.025.1D01, MD.025.1H07, 306.012.7.1C10, 306.012.7.1A05, 10.036.7.1B04, 10.04.7.1B03

APT1 deficient mouse

by | Apr 8, 2020 | Semenkovich, Clay, Wei, Xiaochao

— APT1 deficient mouse

Irg1 point mutant mice

by | Feb 14, 2020 | Diamond, Michael, Nair, Sharmila

— Description: CRISPR-Cas9 gene edited mice with point mutation in Irg1 (ACOD1).

Note: Please contact for additional information.

Chikungunya Monoclonal Antibodies

by | Feb 14, 2020 | Diamond, Michael, Fremont, Daved

— Description: Monoclonal antibodies that react with and/or neutralize Chikungunya virus

Publication:

Novel Monoclonal Antibodies against Dengue Viruses (1,2,3, & 4) E Proteins

by | Feb 10, 2020 | Brien, James, Diamond, Michael, Shrestha, Bimmi, Sukupolvi, Soila

— Description: Monoclonal antibodies against Dengue virus E proteins. These mAbs are generated in mouse against different Dengue viruses and have been shown, by functional assays, to neutralize infection of the individual Dengue serotypes.

Target: Dengue Virus

Notes: Contact for more info.

Publicat…